Optimized Management After Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension (POpPART)
Optimised Management After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension
Balloon pulmonary angioplasty (BPA) is a new method of treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent CTEPH after surgery. BPA improves or even normalises hemodynamic parameters measured during a right heart catheterization. Nevertheless, the vast majority of patients retain dyspnea and impaired exercise capacity despite considerable hemodynamic improvements.
Pulmonary rehabilitation (RHB) can improve symptoms, quality of life and exercise capacity in patients with CTEPH. Unfortunately, access to RHB remains a concern in many countries. Tele-rehabilitation (tRHB) has been shown feasible and effective some cardiac or pulmonary diseases.
This randomized controlled study aims at comparing the effects of tRHB with the effects of simple advices regarding exercising in CTEPH patients with normalized or near-normalized pulmonary hemodynamics after BPA treatment.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of pulmonary embolism leading to dyspnea, effort limitation and sometimes right heart failure and death. Balloon pulmonary angioplasty (BPA) is a new method of treatment for inoperable CTEPH or persistent CTEPH after surgery. BPA restores blood flow in the treated areas and improves or even normalises hemodynamic parameters measured during a right heart catheterization. Nevertheless, the vast majority of patients retain dyspnea and impaired exercise capacity after angioplasty procedures.
Exercise training has been demonstrated to alleviate exercise dyspnea and to improve exercise capacity in many chronic cardiopulmonary conditions. Pulmonary rehabilitation (RHB) can improve symptoms, quality of life and exercise capacity in patients with pulmonary vascular disease of different etiologies including CTEPH. Furthermore, RHB does not present any particular risk for CTEPH patients with normalized or near-normalized pulmonary hemodynamics. Unfortunately, access to RHB remains a concern in many countries. Tele-rehabilitation (tRHB) has been shown feasible and effective some cardiac or pulmonary diseases. Our hypothesis is that tRHB may also be effective in CTEPH patients with normalized or near-normalized pulmonary hemodynamics after BPA treatment.
This randomized controlled study aims at comparing the effects of tRHB with the effects of simple advices regarding exercising in CTEPH patients with normalized or near-normalized pulmonary hemodynamics after BPA treatment.
Tipo de estudio
Inscripción (Anticipado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Bruno Degano, MD, PhD
- Número de teléfono: +33 04 76 76 50 85
- Correo electrónico: BDegano@chu-grenoble.fr
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age > 18 years old
- Patients who have undergone pulmonary angioplasty for CTEPH (group 4 of the international classification)
- Patients with a mean pulmonary artery pressure <= 30 mmHg and cardiac output > 2.5 L/min/m2 at the last angioplasty session
- Patients who had completed an incremental cardiopulmonary exercise test
- Patients affiliated to the French social security system
- Patients with signed informed consent
Exclusion Criteria:
- Patients unable to complete an incremental cardiopulmonary exercise test
- Patients unable to complete a 6-minutes walking test, 3-minutes chair raising test and a rehabilitation
- Patient unable, for technical or any other reason, to connect via the Internet for remote monitoring and/or telerehabilitation
- Patient for whom a refusal to participate in a rehabilitation programme is anticipated
- Patient who has participated in a rehabilitation programme in the 6 months prior to the date of inclusion
- Patients referred to in Articles L1121-5 to L1121-8 of the CSP (pregnant women, parturients, nursing mothers, persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care and adults subject to a legal protection measure or unable to express their consent).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Control
Simple physical activity advices will be given to the 27 patients of the control arm
|
|
|
Experimental: telerehabilitation
Patients in the tele rehabilitation arm will perform 24 1h-telerehabilition sessions (dance, gym, cardio training, yoga, ...)
|
24 sessions (less Thant 1h hour each) of tele rehabilitation.
Patients can choose among several activities (gym, dance, cardio training, ...)
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Difference of endurance time on cycloergometer
Periodo de tiempo: At inclusion and after 3 months
|
Expressed in seconds and calculated as follow: endurance time after 3 months - endurance time at inclusion The two tests are performed at 80% of the maximum power reached during a maximum incremental effort test (performed before inclusion)
|
At inclusion and after 3 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
6-minutes walking test (6MWT)
Periodo de tiempo: At inclusion and at Month 3
|
Distance walked in 6-min (in meters)
|
At inclusion and at Month 3
|
|
3-minutes chair rise test (3-CRT)
Periodo de tiempo: At inclusion and at Month 3
|
Number of rises during 3-CRT (n)
|
At inclusion and at Month 3
|
|
SF-36
Periodo de tiempo: At inclusion and at Month 3
|
Physical dimensions of the SF-36 questionnaire
|
At inclusion and at Month 3
|
|
Dyspnea (NYHA scale)
Periodo de tiempo: At inclusion, at Month 1, Month 2 and Month 3
|
Either I, II, III or IV
|
At inclusion, at Month 1, Month 2 and Month 3
|
|
Telerehabilitation
Periodo de tiempo: Through study completion, an average of 3 months
|
Total number of sessions achieved
|
Through study completion, an average of 3 months
|
|
St George Respiratory Questionnaire (SGRQ)
Periodo de tiempo: At inclusion and at Month 3
|
Total SGRQ score
|
At inclusion and at Month 3
|
|
Dyspnea (mMRC score)
Periodo de tiempo: At inclusion, at Month 1, Month 2 and Month 3
|
Either 0, 1, 2, 3 or 4
|
At inclusion, at Month 1, Month 2 and Month 3
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Bruno Degano, MD, PhD, CHU Grenoble Alpes
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Anticipado)
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- EssaiClinique_POPPART
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre telerehabilitation
-
University of UtahReclutamientoCancer de prostataEstados Unidos
-
University of SalernoAzienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'AragonaReclutamientoInsuficiencia cardiacaItalia
-
University of PatrasTerminadoTelerehabilitación | Diástasis de rectos abdominales | Diástasis De Rectos Y Debilidad De La Linea Alba | Diástasis de los rectos abdominales (DRA)Grecia
-
Teppo SarkamoUniversity of Jyvaskyla; Finnish Brain Association; HUS Neurocenter; HUS Medical... y otros colaboradoresReclutamiento
-
Trak Health Solutions S.L.University Hospital Gregorio MarañónReclutamiento
-
Universita di VeronaReclutamientoEsclerosis múltiple | Telerehabilitación | Neurorehabilitación | Trastornos cognitivosItalia
-
Akdeniz UniversityReclutamientoAccidente cerebrovascular isquémico | EntrenamientoTurquía (Türkiye)
-
University of Castilla-La ManchaAún no reclutandoParálisis Cerebral Infantil
-
Cairo UniversityReclutamiento
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Aún no reclutando